CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parentheticals) - USD ($) |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Apr. 30, 2017 |
Apr. 30, 2016 |
Apr. 30, 2017 |
Apr. 30, 2016 |
|
Research and Development Expense [Member] | ||||
Non-cash Stock Option Compensation Expenses | $ 68,928 | $ 72,496 | $ 148,628 | $ 91,442 |
Selling and Marketing Expense [Member] | ||||
Non-cash Stock Option Compensation Expenses | $ 122,991 | $ 144,758 | $ 303,028 | $ 238,307 |
X | ||||||||||
- Definition Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|